TP53 and neoplasm: Using specific USP14 inhibitors like b‐AP15 can effectively inhibit tumour growth and improve survival in tumour‐bearing mice by regulating cell cycle and apoptosis pathways, providing a potential treatment strategy for p53‐deficient tumours [30].